Interpersonal and Social Rhythm Therapy for Adolescents With Bipolar Disorder
NCT ID: NCT00576355
Last Updated: 2012-06-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
36 participants
INTERVENTIONAL
2007-12-31
2010-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Group Interpersonal Psychotherapy for Depressed Adolescents in School-based Clinics
NCT00270244
Interpersonal Psychotherapy for Adolescents and Young Adults
NCT05575960
Treatment for Borderline Personality Disorder
NCT00055315
Interpersonal Psychotherapy for Depressed Adolescents and Parents
NCT00619411
The Efficacy of Parent Involvement in the Treatment of Adolescent Depression
NCT00883519
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Participants in this study will be randomly assigned to receive interpersonal and social rhythm therapy for adolescents (IPSRT-A) or treatment as usual (TAU). Participants assigned to IPSRT-A will take part in 18 sessions of IPSRT over a 20-week period. Beginning with the first session, participants will meet with a therapist weekly for 16 weeks and then every other week for 4 weeks. Each IPSRT session will last about 45 to 60 minutes, and parents will be asked to accompany the child to 2 to 4 of these sessions. During IPSRT sessions, the therapist will talk with participants about their relationships and how they relate to symptoms; work with participants to help improve understanding of how their social and sleep routines relate to symptoms; and teach participants about bipolar disorder. Participants assigned to TAU will be given educational information about bipolar disorder and its treatment. They will then be referred to a mental health provider for usual care treatment.
All participants and parents will complete questionnaires about symptoms every 4 weeks during the study. Follow-up assessments will occur at the end of treatment and again at Months 3 and 6 post-treatment. These assessments will last between 60 and 90 minutes and will include completing an interview and questionnaires. Participants will also be asked for permission to obtain grade point average (GPA) and attendance records from their schools.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
2
Participants will receive treatment as usual
Treatment As Usual (TAU)
TAU includes the offering of educational information about bipolar disorder and referral to a mental health provider.
1
Participants will receive interpersonal and social rhythm therapy for adolescents
Interpersonal and Social Rhythm Therapy for Adolescents (IPSRT-A)
IPSRT-A involves 20 weeks of individual therapy, incorporating informed psychological, behavioral, and practical strategies adapted to the developmental needs of adolescents.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Interpersonal and Social Rhythm Therapy for Adolescents (IPSRT-A)
IPSRT-A involves 20 weeks of individual therapy, incorporating informed psychological, behavioral, and practical strategies adapted to the developmental needs of adolescents.
Treatment As Usual (TAU)
TAU includes the offering of educational information about bipolar disorder and referral to a mental health provider.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Currently meets DSM-IV criteria for a depressed, manic, hypomanic, or mixed episode
* Youth assent/parental consent to outpatient psychotherapy for treatment of bipolar disorder
* Adequate access to transportation or close proximity in order to participate in therapy
Exclusion Criteria
* Developmentally delayed
* Actively psychotic, suicidal, homicidal, or engages in repeated parasuicidal behaviors
* History of chronic suicidality (e.g., more than three suicidal gestures in the year prior to study entry)
* Neurological or other medical disorder that could potentially cause or complicate presenting psychiatric symptoms
* Meets current DSM-IV criteria for drug or alcohol abuse or dependence
* Life circumstances that would prohibit ability to participate, including absence of shelter or impending jail/prison for more than 2 weeks during study
* Parent/legal guardian refusal to participate with the adolescent
12 Years
19 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of Mental Health (NIMH)
NIH
University of Washington
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Stefanie Hlastala, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Washington, Children's Hospital and Regional Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Seattle Children's Hospital
Seattle, Washington, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.